Cell and Tissue Research

, Volume 318, Issue 1, pp 73–80 | Cite as

Factors promoting survival of mesencephalic dopaminergic neurons

Review

Abstract

Growth factors promoting survival of mesencephalic dopaminergic neurons are discussed in the context of their requirement during development and adulthood. The expression of growth factors should be detectable in the nigrostriatal system during critical periods of development, i.e., during the period of ontogenetic cell death and synaptogenesis and during neurite extension and neurotransmitter synthesis. Growth factors discussed include members of the family of glial-cell-line-derived neurotrophic factors (GDNF), neurotrophins, transforming growth factors beta, and low molecular compounds mimicking growth factor activities. To date, the available data support the notion that GDNF is a highly promising candidate, although GDNF-null mice lack a dopaminergic phenotype. There remains a possibility that endogenous dopaminotrophic factors remain to be discovered.

Keywords

Dopaminergic neurons Growth factors Development Neuron survival Cell death GDNF Parkinson’s disease 

References

  1. Acheson A, Conover JC, Fandl JP, DeChiara TM, Russell M, Thadani A, Squinto SP, Yancopoulos GD, Lindsay RM (1995) A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 374:450–453CrossRefPubMedGoogle Scholar
  2. Airaksinen MS, Saarma M (2002) The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 3:383–394CrossRefPubMedGoogle Scholar
  3. Akerud P, Alberch J, Eketjall S, Wagner J, Arenas E (1999) Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons. J Neurochem 73:70–78CrossRefPubMedGoogle Scholar
  4. Akerud P, Holm PC, Castelo-Branco G, Sousa K, Rodriguez FJ, Arenas E (2002) Persephin-overexpressing neural stem cells regulate the function of nigral dopaminergic neurons and prevent their degeneration in a model of Parkinson’s disease. Mol Cell Neurosci 21:205–222CrossRefPubMedGoogle Scholar
  5. Alderson RF, Alterman AL, Barde YA, Lindsay RM (1990) Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture. Neuron 5:297–306CrossRefPubMedGoogle Scholar
  6. Alexi T, Hefti F (1993) Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture. Neuroscience 55:903–918CrossRefPubMedGoogle Scholar
  7. Arenas E, Trupp M, Akerud P, Ibanez CF (1995) GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 15:1465–1473CrossRefPubMedGoogle Scholar
  8. Baloh RH, Tansey MG, Lampe PA, Fahrner TJ, Enomoto H, Simburger KS, Leitner ML, Araki T, Johnson EM Jr, Milbrandt J (1998) Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex. Neuron 21:1291–1302CrossRefPubMedGoogle Scholar
  9. Baloh RH, Enomoto H, Johnson EM Jr, Milbrandt J (2000) The GDNF family ligands and receptors—implications for neural development. Curr Opin Neurobiol 10:103–110CrossRefPubMedGoogle Scholar
  10. Barde YA, Edgar D, Thoenen H (1982) Purification of a new neurotrophic factor from mammalian brain. EMBO J 1:549–553PubMedGoogle Scholar
  11. Barker V, Middleton G, Davey F, Davies AM (2001) TNFalpha contributes to the death of NGF-dependent neurons during development. Nat Neurosci 4:1194–1198CrossRefPubMedGoogle Scholar
  12. Bartheld CS v (2004) Axonal transport and neuronal transcytosis of trophic factors, tracers, and pathogens. J Neurobiol 58:295–314CrossRefPubMedGoogle Scholar
  13. Berkemeier LR, Winslow JW, Kaplan DR, Nikolics K, Goeddel DV, Rosenthal A (1991) Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB. Neuron 7:857–866CrossRefPubMedGoogle Scholar
  14. Bourque MJ, Trudeau LE (2000) GDNF enhances the synaptic efficacy of dopaminergic neurons in culture. Eur J Neurosci 12:3172–3180CrossRefPubMedGoogle Scholar
  15. Böttner M, Krieglstein K, Unsicker K (2000) The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions. J Neurochem 75:2227–2240CrossRefPubMedGoogle Scholar
  16. Brodski C, Weisenhorn DM, Signore M, Sillaber I, Oesterheld M, Broccoli V, Acampora D, Simeone A, Wurst W (2003) Location and size of dopaminergic and serotonergic cell populations are controlled by the position of the midbrain-hindbrain organizer. J Neurosci 23:4199–4207PubMedGoogle Scholar
  17. Buj-Bello A, Buchman VL, Horton A, Rosenthal A, Davies AM (1995) GDNF is an age-specific survival factor for sensory and autonomic neurons. Neuron 15:821–828CrossRefPubMedGoogle Scholar
  18. Burke RE (2004) Ontogenic cell death in the nigrostriatal system. Cell Tissue Res DOI s00441-004-0908-4
  19. Burke RE, Antonelli M, Sulzer D (1998) Glial cell line-derived neurotrophic growth factor inhibits apoptotic death of postnatal substantia nigra dopamine neurons in primary culture. J Neurochem 71:517–525PubMedGoogle Scholar
  20. Campenout RB, MacInnis BL (2004) Retrograde transport of neurotrophins: fact and function. J Neurobiol 58:217–229CrossRefPubMedGoogle Scholar
  21. Chauhan NB, Siegel GJ, Lee JM (2001) Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson’s disease brain. J Chem Neuroanat 21:277–288CrossRefPubMedGoogle Scholar
  22. Cho J, Kholodilov NG, Burke RE (2004) Patterns of developmental mRNA expression of neurturin and GFRalpha2 in the rat striatum and substantia nigra do not suggest a role in the regulation of natural cell death in dopamine neurons. Dev Brain Res 148:143–149CrossRefPubMedGoogle Scholar
  23. Choi-Lundberg DL, Bohn MC (1995) Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. Dev Brain Res 85:80–88CrossRefGoogle Scholar
  24. Chun HS, Son JJ, Son JH (2000) Identification of potential compounds promoting BDNF production in nigral dopaminergic neurons: clinical implication in Parkinson’s disease. Neuroreport 11:511–514PubMedGoogle Scholar
  25. Conner JM, Lauterborn JC, Gall CM (1998) Anterograde transport of neurotrophin proteins in the CNS—reassessment of the neurotrophic hypothesis. Rev Neurosci 9:91–103PubMedGoogle Scholar
  26. Constantini LC, Chaturvedi P, Armistead DM, McCaffrey PG, Deacon TW, Isacson O (1998) A novel immunophilin ligand: distinct branching effects on dopaminergic neurons in culture and neurotrophic actions after oral administration in an animal model of Parkinson’s disease. Neurobiol Dis 5:97–106CrossRefPubMedGoogle Scholar
  27. Constantini LC, Cole D, Chaturvedi P, Isacson O (2001) Immunophilin ligands can prevent progressive dopaminergic degeneration in animal models of Parkinson’s disease. Eur J Neurosci 13:1085–1092CrossRefPubMedGoogle Scholar
  28. Creange A, Barlovatz-Meimon G, Gherardi RK (1997) Cytokines and peripheral nerve disorders. Eur Cytokine Netw 8:145–151PubMedGoogle Scholar
  29. Davies AM (1998) Developmental changes in the neurotrophic factor survival requirements of peripheral nervous system neurons. Prog Brain Res 117:47–56PubMedGoogle Scholar
  30. DiStefano PS, Friedman B, Radziejewski C, Alexander C, Boland P, Schick CM, Lindsay RM, Wiegand SJ (1992) The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron 8:983–993CrossRefPubMedGoogle Scholar
  31. Dluzen DE, Story GM, Xu K, Kucera J, Walro JM (1999) Alterations in nigrostriatal dopaminergic function within BDNF mutant mice. Exp Neurol 160:500–507CrossRefPubMedGoogle Scholar
  32. Eberhardt O, Coelln RV, Kugler S, Lindenau J, Rathke-Hartlieb S, Gerhardt E, Haid S, Isenmann S, Gravel C, Srinivasan A, Bahr M, Weller M, Dichgans J, Schulz JB (2000) Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson’s disease. J Neurosci 20:9126–9134PubMedGoogle Scholar
  33. Emborg ME, Shin P, Sramek JG, Chu Y, Stebbins GT, Hamilton JS, Suzdak PD, Steiner JP Korsower JH (2001) Systemic administration of the immunophilin ligand GPI 1046 in MPTP-treated monkeys. Exp Neurol 168:171–182CrossRefPubMedGoogle Scholar
  34. Engele J, Rieck H, Choi-Lundberg D, Bohn MC (1996) Evidence for a novel neurotrophic factor for dopaminergic neurons secreted from mesencephalic glial cell lines. J Neurosci Res 43:576–586CrossRefPubMedGoogle Scholar
  35. Enokido Y, Sauvage F de, Hongo JA, Ninkina N, Rosenthal A, Buchman VL, Davies AM (1998) GFR alpha-4 and the tyrosine kinase Ret form a functional receptor complex for persephin. Curr Biol 8:1019–1022CrossRefPubMedGoogle Scholar
  36. Ernfors P, Ibanez CF, Ebendal T, Olson L, Persson H (1990) Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Proc Natl Acad Sci USA 87:5454–5458PubMedGoogle Scholar
  37. Farkas LM, Krieglstein K (2002) Heparin-derived epidermal growth factor-like growth factor (HB-EGF) regulates survival of midbrain dopaminergic neurons. J Neural Transm 109:267–277CrossRefPubMedGoogle Scholar
  38. Farkas L, Suter-Crazzolara C, Unsicker K (1997) GDNF induces the calretinin phenotype in cultures of embryonic striatal neurons. J Neurosci Res 50:361–372CrossRefPubMedGoogle Scholar
  39. Farkas L, Dünker N, Roussa E, Unsicker K, Krieglstein K (2003) TGF-βs are essential for the development of midbrain dopaminergic neurons in vitro and in vivo. J Neurosci 23:5178–5186PubMedGoogle Scholar
  40. Flanders KC, Lüdecke G, Engels S, Cissel DS, Roberts AB, Kondaiah P, Lafyatis R, Sporn MB, Unsicker K (1991) Immunhistochemical localization of transforming growth factor-βs in the nervous system of the mouse embryo. Development 113:183–191PubMedGoogle Scholar
  41. Frade JM, Barde YA (1998) Nerve growth factor: two receptors, multiple functions. Bioessays 20:137–145CrossRefPubMedGoogle Scholar
  42. Fricker G, Miller DS (2004) Modulation of drug transporters at the blood-brain barrier. Pharmacology 70:169–176CrossRefPubMedGoogle Scholar
  43. Friedman WJ, Olson L, Persson H (1991) Cells that express brain-derived neurotrophic factor mRNA in the developing postnatal rat brain. Eur J Neurosci 3:688–697PubMedGoogle Scholar
  44. Gall CM, Gold SJ, Isackson PJ, Seroogy KB (1992) Brain-derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons. Mol Cell Neurosci 3:56–63Google Scholar
  45. Gash DM, Zhang Z, Ovadia A, Cass WA, Yi A, Simmerman L, Russell D, Martin D, Lapchak PA, Collins F, Hoffer BJ, Gerhardt GA (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380:252–255CrossRefPubMedGoogle Scholar
  46. Georgievska B, Kirik D, Björklund A (2002) Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Exp Neurol 177:461–474CrossRefPubMedGoogle Scholar
  47. Guo X, Dillman JF III, Dawson VL, Dawson TM (2001) Neuroimmunophilins: novel neuroprotective and neuroregenerative targets. Ann Neurol 50:6–16CrossRefPubMedGoogle Scholar
  48. Hallbook F, Ibanez CF, Persson H (1991) Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron 6:845–858CrossRefPubMedGoogle Scholar
  49. Henderson CE, Phillips HS, Pollock RA, Davies AM, Lemeulle C, Armanini MP, Simpson, LC, Moffet B, Vandlen RA, Koliatsos VE, Rosenthal A (1994) GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266:1062–1064PubMedGoogle Scholar
  50. Hoane MR, Gulwadi AG, Morrison S, Hovanesian G, Lindner MD, Tao W (1999) Differential in vivo effects of neurturin and glial cell-line-derived neurotrophic factor. Exp Neurol 160:235–243CrossRefPubMedGoogle Scholar
  51. Hofer M, Pagliusi SR, Hohn A, Leibrock J, Barde YA (1990) Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J 9:2459–2464PubMedGoogle Scholar
  52. Hohn A, Leibrock J, Bailey K, Barde YA (1990) Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature 344:339–341CrossRefPubMedGoogle Scholar
  53. Horger BA, Nishimura MC, Armanini MP, Wang LC, Poulsen KT, Rosenblad C, Kirik D, Moffat B, Simmons L, Johnson E Jr, Milbrandt J, Rosenthal A, Bjorklund A, Vandlen RA, Hynes MA, Phillips HS (1998) Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons. J Neurosci 18:4929–4937PubMedGoogle Scholar
  54. Huang EJ, Reichardt LF (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72:609–642CrossRefPubMedGoogle Scholar
  55. Hudson J, Granholm A-C, Gerhardt GA, Henry MA, Hoffmann A, Biddle P, Leela NS, Mackerlova L, Lile JD, Collins F, Hoffer BJ (1995) Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res Bull 36:425–432CrossRefPubMedGoogle Scholar
  56. Hyman C, Hofer M, Barde Y-A, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230–232CrossRefPubMedGoogle Scholar
  57. Hyman C, Juhasz M, Jackson C, Wright P, Ip NY, Lindsay RM (1994) Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic neurons of the ventral mesencephalon. J Neurosci 14:335–347PubMedGoogle Scholar
  58. Hynes MA, Poulsen K, Armanini M, Berkemeier L, Phillips H, Rosenthal A (1994) Neurotrophin 4/5 is a survival factor for embryonic midbrain dopaminergic neurons in enriched cultures. J Neurosci Res 37:144–154PubMedGoogle Scholar
  59. Ip NY, Ibanez CF, Nye SH, McClain J, Jones PF, Gies DR, Belluscio L, Beau MM, Espinoza R III, Squinto SP, Perssön H, Yancopoulos G (1992) Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution and receptor specificity. Proc Natl Acad Sci USA 89:3060–3064PubMedGoogle Scholar
  60. Jaszai J, Farkas LM, Galter D, Reuss B, Strelau J, Unsicker K, Krieglstein K (1998) The GDNF-related factor persephin is widely distributed throughout the nervous system. J Neurosci Res 53:494–501CrossRefPubMedGoogle Scholar
  61. Jordan J, Böttner M, Schluesener H, Unsicker K, Krieglstein K (1997) Bone morphogenetic proteins: neurotrophic roles for midbrain dopaminergic neurons and implications of astroglial cells. Eur J Neurosci 9:1699–1710PubMedGoogle Scholar
  62. Kholodilov N, Yarygina O, OoTF, Zhang H, Sulzer D, Dauer W, Burke RE (2004) Regulation of developmental mesencephalic dopaminergic systems by the selective expression of glial cell line-derived neurotrophic factor in their targets. J Neurosci 24:3136–3146CrossRefPubMedGoogle Scholar
  63. Kinameri E, Matsuoka I (2003) Autocrine action of BPM2 regulates expression of GDNF-mRNA in sciatic Schwann cells. Mol Brain Res 117:221–227CrossRefPubMedGoogle Scholar
  64. Klein R (1994) Role of neurotrophins in mouse neuronal development. FASEB J 8:738–744PubMedGoogle Scholar
  65. Knusel B, Winslow JW, Rosenthal A, Burton LE, Seid DP, Nikolics K, Hefti F (1991) Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc Natl Acad Sci USA 88:951–955PubMedGoogle Scholar
  66. Kordower JH (2003) In vivo gene therapy of glial cell line-derived neurotrophic factor for Parkinson’s disease. Ann Neurol 53:S120–S132CrossRefPubMedGoogle Scholar
  67. Korsching S (1993) The neurotrophic factor concept: a reexamination. J Neurosci 13:2739–2748PubMedGoogle Scholar
  68. Kraemer R, Hemstead BL (2003) Neurotrophins: novel mediators of angiogenesis. Front Biosci 8:s1181–s1186PubMedGoogle Scholar
  69. Krieglstein K, Suter-Crazzolara C, Fischer WH, Unsicker K (1995a) TGF-β superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO J 14:736–742PubMedGoogle Scholar
  70. Krieglstein K, Suter-Crazzolara C, Hötten G, Pohl J, Unsicker K (1995b) Trophic and protective effects of GDF5, a member of the TGF-β superfamily, on midbrain dopaminergic neurons. J Neurosci Res 42:724–732PubMedGoogle Scholar
  71. Krieglstein K, Henheik P, Farkas L, Jaszai J, Galter D, Krohn K, Unsicker K (1998) GDNF requires TGF-β for establishing its neurotrophic activity. J Neurosci 18:9822–9834PubMedGoogle Scholar
  72. Krieglstein K, Richter S, Farkas L, Schuster N, Dunker N, Oppenheim RW, Unsicker K (2000) Reduction of endogenous transforming growth factors beta prevents ontogenetic neuron death. Nat Neurosci 3:1085–1090CrossRefPubMedGoogle Scholar
  73. Lau YS, Hao R, Fung YK, Fu LS, Bishop JF, Pfeiffer RF, Mouradian MM (1998) Modulation of nigrostriatal dopaminergic transmission by antisense oligodeoxynucleotide against brain-derived neurotrophic factor. Neurochem Res 23:525–532CrossRefPubMedGoogle Scholar
  74. Legutko B, Li X, Skolnick P (2001) Regulation of BDNF expression in primary neuron culture by LY392098, a novel AMPA receptor potentiator. Neuropharmacology 40:1019–1027CrossRefPubMedGoogle Scholar
  75. Leibrock J, Lottspeich F, Hohn A, Hofer M, Hengerer B, Masiakowski P, Thoenen H, Barde YA (1989) Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341:149–152CrossRefPubMedGoogle Scholar
  76. Leung SYD, Unsicker K, Reuss B (2001) Gap junctions modulate survival-promoting effects of fibroblast growth factor-2 on cultured midbrain dopamonergic neurons. Mol Cell Neurosci 18:44–55CrossRefPubMedGoogle Scholar
  77. Levi-Montalcini R (1987) The nerve growth factor 35 years later. Science 237:1154–1162PubMedGoogle Scholar
  78. Lewin GR, Barde Y-A (1996) Physiology of the neurotrophins. Annu Rev Neurosci 19:289–317CrossRefPubMedGoogle Scholar
  79. Lin LFH, Doherty DH, Lile JD, Bektesh S, Collins F (1993) GDNF—a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130–1132PubMedGoogle Scholar
  80. Lu X, Maysinger D, Hagg T (2002) Tyrosine phosphatase inhibition enhances neurotrophin potency and rescues nigrostriatal neurons in adult rats. Exp Neurol 178:259–267CrossRefPubMedGoogle Scholar
  81. Maisonpierre PC, Belluscio L, Squinto S, Ip NY, Furth ME, Lindsay RM, Yancopoulos GD (1990) Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science 247:1446–1451PubMedGoogle Scholar
  82. Merlio JP, Ernfors P, Jaber M, Persson H (1992) Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system. Neuroscience 51:513–532CrossRefPubMedGoogle Scholar
  83. Miao N, Wang M, Ott JA, D’Alessandro JS, Woolf TM, Bumcrot DA, Mahanthappa NK, Pang K (1997) Sonic hedgehog promotes the survival of specific CNS neuron populations and protects these cells from toxic insult in vitro. J Neurosci 17:5891–5899PubMedGoogle Scholar
  84. Milbrandt J, Sauvage FJ de, Fahrner TJ, Baloh RH, Leitner ML, Tansey MG, Lampe PA, Heuckeroth RO, Kotzbauer PT, Simburger KS, Golden JP, Davies JA, Vejsada R, Kato AC, Hynes M, Sherman D, Nishimura M, Wang LC, Vandlen R, Moffat B, Klein RD, Poulsen K, Gray C, Garces A, Johnson EM Jr (1998) Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron 20:245–253CrossRefPubMedGoogle Scholar
  85. Mufson EJ, Kroin JS, Sobreviela T, Burke MA, Kordower JH, Penn RD, Miller JA (1994) Intrastriatal infusions of brain-derived neurotrophic factor: retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat. Exp Neurol 129:15–26CrossRefPubMedGoogle Scholar
  86. Mufson EJ, Kroin JS, Sendera TJ, Sobreviela T (1999) Distribution and retrograde transport of trophic factors in the central nervoussystem: functional implications for the treatment of neurodegenerative diseases. Prog Neurobiol 57:451–484CrossRefPubMedGoogle Scholar
  87. Nakayama T, Momoki-Soga T, Inoue N (2003) Astrocyte-derived factors instruct differentiation of embryonic stem cells into neurons. Neurosci Res 46:241–249PubMedGoogle Scholar
  88. Nathan C, Sporn M (1991) Cytokines in context. J Cell Biol 113:981–986CrossRefPubMedGoogle Scholar
  89. Numan S, Seroogy KB (1999) Expression of trkB and trkC mRNAs by adult midbrain dopaminergic neurons: a double-label in situ hybridization study. J Comp Neurol 403:295–308CrossRefPubMedGoogle Scholar
  90. O’Neill MJ, Murray TK, Whalley K, Ward MA, Hicks CA, Woodhouse S, Osborne DJ, Skolnick P (2004) Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson’s disease. Eur J Pharmacol 486:163–174CrossRefPubMedGoogle Scholar
  91. Oo TF, Burke RE (1997) The time course of developmental cell death in phenotypically defined dopaminergic enurons of the substantia nigra. Dev Brain Res 98:191–196CrossRefGoogle Scholar
  92. Oo TF, Kholodilov N, Burke RE (2003) Regulation of natural cell death in dopaminergic neurons of the substantia nigra by striatal glial cell line-derived neurotrophic factor in vivo. J Neurosci 23:5141–5148PubMedGoogle Scholar
  93. Oppenheim RW (1991) Cell death during development of the nervous system. Annu Rev Neurosci 14:453–501CrossRefPubMedGoogle Scholar
  94. Otten U, Gadient RA (1995) Neurotrophins and cytokines—intermediaries between the immune and nervous system. Int J Dev Neurosci 13:147–151CrossRefPubMedGoogle Scholar
  95. Otto D, Unsicker K (1990) Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J Neurosci 10:1912–1921PubMedGoogle Scholar
  96. Pan W, Kastin AJ (2004) Polypeptide delivery across the blood-brain barrier. Curr Drug Targets Neurol Disord 3:131–136Google Scholar
  97. Perrelet D, Ferri A, Liston P, Muzzin P, Korneluk RG, Kato AC (2002) IAPs are essential for GDNF-mediated neuroprotective effects in injured motorneurons in vivo. Nat Cell Biol 4:175–179CrossRefPubMedGoogle Scholar
  98. Poulsen KT, Armanini MP, Klein RD, Hynes MA, Phillips HS, Rosenthal A (1994) TGFβ2 and TGFβ3 are potent survival factors for midbrain dopaminergic neurons. Neuron 13:1245–1252CrossRefPubMedGoogle Scholar
  99. Raoul C, Pettmann B, Henderson CE (2000) Active killing of neurons during development and following stress: a role for p75(NTR) and Fas? Curr Opin Neurobiol 10:111–117CrossRefPubMedGoogle Scholar
  100. Rite I, Venero JT, Tomas-Camardiel M, Machado A, Cano J (2003) Expression of BDNF mRNA in substantia nigra is dependent on target integrity and independent of neuronal activation. J Neurochem 87:709–721CrossRefPubMedGoogle Scholar
  101. Roberts AB, Sporn MB (1990) The transforming growth factors-βs. In: Sporn MB, Roberts AB (eds) Handbook of experimental pharmacology, vol 95. Springer, Berlin Heidelberg New York, pp 419–472Google Scholar
  102. Rosenblad C, Gronborg M, Hansen C, Blom N, Meyer M, Johansen J, Dago L, Kirik D, Patel UA, Lundberg C, Trono D, Björklund A, Johansen TE (2000) In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin. Mol Cell Neurosci 15:199–214CrossRefPubMedGoogle Scholar
  103. Rosenthal A, Goeddel DV, Nguyen T, Lewis M, Shih A, Laramee GR, Nikolics K, Winslow JW (1990) Primary structure and biological activity of a human neurotrophic factor. Neuron 4:767–773PubMedGoogle Scholar
  104. Roussa E, Krieglstein K (2004) Induction and specification of dopaminergic development. Cell Tissue Res DOI s00441-004-0916-4
  105. Roussa E, Faskas L, Krieglstein K (2004) TGF-beta promotes survival of mesencephalic dopaminergic neurons in cooperation with Shh and FGF-8. Neurobiol Dis 16:300–310CrossRefPubMedGoogle Scholar
  106. Saarma M (2000) GDNF—a stranger in the TGF-beta superfamily? Eur J Biochem 267:6968–6971CrossRefPubMedGoogle Scholar
  107. Sariola H, Saarma M (2003) Novel functions and signalling pathways for GDNF. J Cell Sci 116:2855–2862CrossRefGoogle Scholar
  108. Schaar DG, Sieber B-A, Dreyfus CF, Black IB (1993) Regional and cell-specific expression of GDNF in rat brain. Exp Neurol 124:368–371CrossRefPubMedGoogle Scholar
  109. Schaar DG, Sieber BA, Sherwood AC, Dean D, Mendoza G, Ramakrishnan L, Dreyfus CF, Black IB (1994) Multiple astrocyte transcripts encode nigral trophic factors in rat and human. Exp Neurol 130:387–393CrossRefPubMedGoogle Scholar
  110. Segal RA (2003) Selectivity in neurotrophin signaling: theme and variations. Annu Rev Neurosci 26:299–330CrossRefPubMedGoogle Scholar
  111. Sendtner M, Pei G, Beck M, Schweizer U, Wiese S (2000) Developmental motoneuron cell death and neurotrophic factors. Cell Tissue Res 301:71–84CrossRefPubMedGoogle Scholar
  112. Seroogy KB, Lundgren KH, Tran TM, Guthrie KM, Isackson PJ, Gall CM (1994) Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J Comp Neurol 342:321–334PubMedGoogle Scholar
  113. Shen RY, Altar CA, Choido LA (1994) Brain-derived neurotrophic factor increases the electrical activity of pars compact a dopamine neurons in vivo. Proc Natl Acad Sci USA 91:8920–8924PubMedGoogle Scholar
  114. Siegel GJ, Chauhan NB (2000) Neurotrophic factors in Alzheimer’s and Parkinson’s disease brain. Brain Res Rev 33:199–227CrossRefPubMedGoogle Scholar
  115. Snider WD (1994) Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 77:627–638CrossRefPubMedGoogle Scholar
  116. Springer JE, Mu X, Bergmann LW, Trojanowski JQ (1994) Expression of GDNF mRNA in rat and human nervous tissue. Exp Neurol 127:167–170CrossRefPubMedGoogle Scholar
  117. Steiner JP, Hamilton GS, Ross DT, Valentine HL, Guo H, Connolly MA, Liang S, Ramsey C, Li JH, Huang W, Howorth P, Soni R, Fuller M, Sauer H, Nowotnik AC, Suzdak PD (1997) Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc Natl Acad Sci USA 94:2019–2024CrossRefPubMedGoogle Scholar
  118. Strelau J, Sullivan A, Böttner M, Lingor P, Falkenstein E, Suter-Crazzolara C, Galter D, Jaszai J, Krieglstein K, Unsicker K (2000) GDF-15/MIC-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo. J Neurosci 20:8597–8603PubMedGoogle Scholar
  119. Thoenen H, Bandtlow C, Heumann R (1987) The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rev Physiol Biochem Pharmacol 109:145–178PubMedGoogle Scholar
  120. Trupp M, Ryden M, Jornvall H, Funakoshi H, Timmusk T, Arenas E, Ibanez CF (1995) Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J Cell Biol 130:137–148CrossRefPubMedGoogle Scholar
  121. Trupp M, Scott R, Wittmore SR, Ibanez CF (1999) Ret-dependent and -independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells. J Biol Chem 274:20885–20894CrossRefPubMedGoogle Scholar
  122. Unsicker K, Krieglstein K (2000) Co-activation of TGF-β and cytokine signaling pathways are required for neurotrophic functions. Cytokines Growth Factor Rev 11:97–102CrossRefGoogle Scholar
  123. Unsicker K, Flanders KC, Cissel DS, Lafyatis R, Sporn MB (1991) Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system. Neuroscience 44:613–625CrossRefPubMedGoogle Scholar
  124. Unsicker K, Suter-Crazzolara C, Krieglstein K (1999) Neurotrophic roles of GDNF and related factors. Handbook Exp Pharmacol 134:189–224Google Scholar
  125. Widenfalk J, Nosrat C, Tomac A, Westphal H, Hoffer B, Olson L (1997) Neurturin and glial cell line-derived neurotrophic factor receptor-beta (GDNFR-beta), novel proteins related to GDNF and GDNFR-alpha with specific cellular patterns of expression suggesting roles in the developing and adult nervous system and in peripheral organs. J Neurosci 17:8506–8519PubMedGoogle Scholar
  126. Wiegand SJ, Anderson K, Alexander C, Criden M, Altar CA, Lindsay RM, DiStefano PS (1992) Receptor binding and axonal transport of 125I-labeled neurotrophins in the basal ganglia and related brain regions. Mov Disord 7:63Google Scholar
  127. Xiao H, Hirata Y, Isobe K, Kiuchi K (2002) Glial cell line-derived neurotrophic factor up-regulates the expression of tyrosine hydroxylase gene in human neuroblastoma cell lines. J Neurochem 82:801–808CrossRefPubMedGoogle Scholar
  128. Zafra F, Hengerer B, Leibrock J, Thoenen H, Lindholm D (1990) Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non-NMDA glutamate receptors. EMBO J 9:3545–3550PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  1. 1.Department Neuroanatomy, Medical Faculty, Center for Molecular Physiology of the Brain (CMPB)University of GöttingenGöttingenGermany

Personalised recommendations